有机化学人才网 | 最新人才 | 最新职位 | 技术交易 | 药物合成 |
   
全站搜索: |
  您当前位置:网站首页 >> 药物合成路线图解
 

药物详细合成路线

Name Curcumin
Chemical Name (E,E)-1,7-Bis(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione
CAS 458-37-7
Related CAS
Formula C21H20O6
Structure
Formula Weight 368.38995
Stage I/II 期临床
Company Central Drug Research Institute (Originator)
Activity/Mechanism AIDS Medicines, Alzheimers Dementia, Treatment of , Antiarthritic Drugs, Anti-HIV Agents, ANTIINFECTIVE THERAPY, Chemopreventive Agents, Cognition Disorders, Treatment of, NEUROLOGIC DRUGS, ONCOLYTIC DRUGS, TREATMENT OF MUSCULOSKELETAL & CONNECTIVE TISSUE DISEASES, Antioxidants, CCND1 Expression Inhibitors, HIV Integrase Inhibitors
Syn. Route 3
Route 1
synthesis of curcumin was first described by lampe et al. in our laboratory curcumin has been synthesized by condensing vanillin (i) and acetyl acetone (ii) in a medium of ethyl acetate using tributylborate as boron complex to avoid knoevenagel condensation at c-3 of acetyl acetone. curcumin is isolated from the reaction mixture by acidification and extraction with ethyl acetate. the organic layers are washed until neutral, dried and the solvent is removed. purified by chromatography over silica gel using ether/petroleum ether as the solvent.
List of intermediates No.
bis(chlorosulfonyl)imide (ii)
4-fluoro-2-hydroxy-n-(3-nitrobenzyl)benzamide (i)
Reference 1:
    scrimal, r.c.; curcumin. drugs fut 1987, 12, 4, 331.

Route 2
the protection of 4-bromo-2-methoxyphenol (i) with ethyl vinyl ether (ii) and tsoh in dichloromethane gives the ethoxyethyl ether (iii), which is treated with n-buli in thf to yield the phenyl lithium compound (iv). the reaction of (iv) with 2h-labeled dmf (v), followed by hydrolysis with hcl, affords the labeled 4-hydroxy-3-methoxybenzaldehyde (vi), which is finally condensed with pentane-2,4-dione (vii) by means of b2o3 and tetrahydroquinoline in dmf.
List of intermediates No.
n-benzoyl-n-(2-hydroxy-4-methylphenyl)thiourea (vii)
1-[(2r,4s,5r)-4-(benzyloxy)-5-(hydroxymethyl)tetrahydro-2-furanyl]-5-iodo-2,4(1h,3h)-pyrimidinedione (ii)
4-fluoro-2-hydroxy-n-(3-nitrobenzyl)benzamide (vi)
(2r,3r,4s,5r,6r)-2-(hydroxymethyl)-6-[(2-tetradecylhexadecyl)oxy]tetrahydro-2h-pyran-3,4,5-triol (v)
(3ar,12bs)-2-(bromomethyl)-3,3a,8,12b-tetrahydro-2h-dibenzo[3,4:6,7]cyclohepta[1,2-b]furan (i)
tert-butyl (3s)-3-[(4-methyl-1h-imidazol-1-yl)methyl]-1-piperidinecarboxylate (iii)
(3r)-3-[(4-methyl-1h-imidazol-1-yl)methyl]piperidine (iv)
7-hydroxy-4-methyl-2h-pyrano[2,3-b]pyridin-2-one (v)
o-(4-methyl-2-oxo-2h-pyrano[2,3-b]pyridin-7-yl) dimethylcarbamothioate (vi)
Reference 1:
    threadgill, m.d.; parveen, i.; labelled compounds of interest as antitumour agents - vii. [h-2]- and [c-14]-curcumin. j label compd radiopharm 2000, 43, 9, 883.

Route 3
the protection of 4-bromo-2-methoxyphenol (i) with ethyl vinyl ether (ii) and tsoh in dichloromethane gives the ethoxyethyl ether (iii), which is treated with n-buli in thf to yield the phenyl lithium compound (iv). the reaction of (iv) with 14c-labeled dmf (v), followed by hydrolysis with hcl, affords the labeled 4-hydroxy-3-methoxybenzaldehyde (vi), which is finally condensed with pentane-2,4-dione (vii) by means of b2o3 and tetrahydroquinoline in dmf.
List of intermediates No.
n-benzoyl-n-(2-hydroxy-4-methylphenyl)thiourea (vii)
1-[(2r,4s,5r)-4-(benzyloxy)-5-(hydroxymethyl)tetrahydro-2-furanyl]-5-iodo-2,4(1h,3h)-pyrimidinedione (ii)
4-fluoro-2-hydroxy-n-(3-nitrobenzyl)benzamide (vi)
(2r,3r,4s,5r,6r)-2-(hydroxymethyl)-6-[(2-tetradecylhexadecyl)oxy]tetrahydro-2h-pyran-3,4,5-triol (v)
(3ar,12bs)-2-(bromomethyl)-3,3a,8,12b-tetrahydro-2h-dibenzo[3,4:6,7]cyclohepta[1,2-b]furan (i)
tert-butyl (3s)-3-[(4-methyl-1h-imidazol-1-yl)methyl]-1-piperidinecarboxylate (iii)
(3r)-3-[(4-methyl-1h-imidazol-1-yl)methyl]piperidine (iv)
s-(4-methyl-2-oxo-2h-pyrano[2,3-b]pyridin-7-yl) dimethylcarbamothioate (v)
4-methyl-7-sulfanyl-2h-pyrano[2,3-b]pyridin-2-one (vi)
Reference 1:
    threadgill, m.d.; parveen, i.; labelled compounds of interest as antitumour agents - vii. [h-2]- and [c-14]-curcumin. j label compd radiopharm 2000, 43, 9, 883.

来源:药化网

作者:药化小编

摘要:本文合成路线介绍的是药物中文名姜黄素;英文名Curcumin;CAS[458-37-7]

 
推荐VIP企业
无锡景耀生物科技有限公司
杭州卢普生物科技有限公司
宁波赛伦化工有限公司
苏州昊赛生物科技有限公司
北京嘉盛扬医药科技有限公司
上海泽涵生物医药科技有限公司
河北固安三利化工公司
郑州凯普瑞生物技术有限公司
上海药谷药业有限公司
兰州康寓信生物科技有限公司
湖北朗昕生化药业有限公司
武汉福鑫化工有限公司
嘉兴市英南化工有限公司
苏州迪飞医药科技有限公司
唐山盛源泽兴化工有限公司
上海盛中医药化工有限公司
连云港天和化学有限公司
南京晨瑞医药科技有限公司
南京苏如化工有限公司
常州瑞盛化工有限公司
热门文章
信息素制造新方法,产品价格有望
农药行业未来形势依然严峻,这五
无交互抗性的新型杀虫杀螨剂——
化工园区可持续发展5大进展+5
生物农药“叫好不叫座”,根本原
卢森堡将自2021年起禁止草甘
10年时间成为大豆杀菌剂市场领
我国自主开发的首个植物生长调节
预判:从全国植保会看2020年
苏利股份拟增资百力化学超700
2019版食品中农药最大残留限
不忘初心,严加管控——专家谈确
第12批!45个拟批准登记农药
山东省农作物病虫预报:小麦/玉
2019年农药市场谁主沉浮?
这29条环境违法行为可举报!奖
因抗药性,这些农药已失效了,怎
安道麦推出新产品,并将致力于完
经历行业寒冬仍期许未来,农化巨
中山集团省级新产品通过鉴定,先
 友情链接
有机化学人才网  
首页 | 广告服务 | 建站服务 | 关于我们 | 联系我们 | 版权声明